|
Goff, Donald C; Herz, Lawrence; Posever, Thomas et al. (2005) A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients. Psychopharmacology (Berl) 179:144-50
|
|
Pascual-Leone, Alvaro; Manoach, Dara S; Birnbaum, Robert et al. (2002) Motor cortical excitability in schizophrenia. Biol Psychiatry 52:24-31
|
|
Coyle, Joseph T; Tsai, Guochuan; Goff, Donald C (2002) Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr Drug Targets CNS Neurol Disord 1:183-9
|
|
Goff, D C; Coyle, J T (2001) The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158:1367-77
|
|
Goff, D C; Henderson, D C; Evins, A E et al. (1999) A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia. Biol Psychiatry 45:512-4
|
|
Goff, D C; Tsai, G; Levitt, J et al. (1999) A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 56:21-7
|
|
Goff, D C; Wine, L (1997) Glutamate in schizophrenia: clinical and research implications. Schizophr Res 27:157-68
|
